Vikas Sinha

2021

In 2021, Vikas Sinha earned a total compensation of $6.6M as President and Chief Financial Officer at Allovir, a 5% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$191,250
Option Awards$3,522,326
Salary$425,000
Stock Awards$2,478,420
Other$6,000
Total$6,622,996

Sinha received $3.5M in option awards, accounting for 53% of the total pay in 2021.

Sinha also received $191.3K in non-equity incentive plan, $425K in salary, $2.5M in stock awards and $6K in other compensation.

Rankings

In 2021, Vikas Sinha's compensation ranked 1,879th out of 12,415 executives tracked by ExecPay. In other words, Sinha earned more than 84.9% of executives.

ClassificationRankingPercentile
All
1,879
out of 12,415
85th
Division
Manufacturing
700
out of 5,501
87th
Major group
Chemicals And Allied Products
260
out of 2,371
89th
Industry group
Drugs
220
out of 2,092
90th
Industry
Biological Products, Except Diagnostic Substances
63
out of 449
86th
Source: SEC filing on April 6, 2022.

Sinha's colleagues

We found four more compensation records of executives who worked with Vikas Sinha at Allovir in 2021.

2021

David Hallal

Allovir

Chairman

2021

Diana Brainard

Allovir

Chief Executive Officer

2021

Agustin Melian

Allovir

Chief Medical Officer

2021

Jeroen van Beek

Allovir

Chief Commercial Officer

News

In-depth

You may also like